Genestack’s Statement on Ukraine
March 17, 2022
We have already made our position very clear in regard to the invasion of Ukraine. We condemn the attacks of the Russian government, and we stand with the Ukrainian people, including our own colleagues and their families. Today we are announcing that we will be suspending all our activities in Russia indefinitely. Genestack was founded in Cambridge, [...]
Kieran P. Murphy, Former CEO of GE Healthcare, Joins Gamma Biosciences as Executive Chairman
March 16, 2022
MENLO PARK, Calif. -- Gamma Biosciences, a global life sciences company formed by KKR to serve the advanced therapy market with best-in-class bioprocessing solutions, today announced that Kieran P. Murphy will join its Board of Directors as Executive Chairman. With a long track record of building leading businesses in biopharma and life sciences, Mr. Murphy [...]
Vector Laboratories Selects Newark, CA for New Corporate Headquarters
March 16, 2022
Relocation driven by increased demand for Vector Laboratories’ growing areas of focus, glycomics and proteomics Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today opened its new facility in Newark, California, where it will relocate its corporate headquarters this year. The relocation is accompanied by the rebranding and launch of a new corporate [...]
March 16, 2022
Financing demonstrates the value of Laminar Wash technology in accelerating and standardizing therapeutic research and development WOBURN, Mass. -- Curiox Biosystems, Inc., the global leader in biological sample preparation automation, announced today the completion of a $15 million (17.1 billion won) Series C financing round. Luha Private Equity led the deal, joined by other existing investors KB Investment Co., [...]
Congenica to Provide Tertiary Analysis for Whole Genome Sequencing for Hong Kong Genome Project
March 16, 2022
Cambridge, United Kingdom – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces that it has been selected to provide tertiary analysis for whole genome sequencing services for the Hong Kong Genome Project (HKGP), the first large-scale genome sequencing initiative in Hong Kong. The HKGP, being [...]
Parallel Photoreactor Offers Easy Interchangeable Wavelength Excitation
March 16, 2022
Asynt has introduced a new modular version of its popular LightSyn Illumin8 photoreactor. This innovative system provides researchers with the flexibility to change quickly and safely between a selection of high-power light emitting diodes (LEDs) operating at wavelengths including UV (365 nm) and blue (450 nm). The LightSyn Illumin8 allows chemists to run up to 8 [...]
Corbeau Innovation named as New UK Distributor for ELODIZ Ltd
March 16, 2022
We are delighted to announce the appointment of Corbeau Innovation as authorised distributor of ELODIZ Raman products in the UK with exclusive distribution rights from 16 March 2022. Based in Cardiff, Corbeau Innovation specialises in innovative spectroscopy products. They partner companies with disruptive technologies, helping them to rapidly develop and sell their products, targeting markets [...]
March 16, 2022
Gibco CTS Xenon Electroporation System complements Thermo Fisher Scientific’s portfolio of end-to-end cell therapy solutions CARLSBAD, Calif. – Thermo Fisher Scientific, the world leader in serving science, has introduced a new large-volume electroporation system that allows cell therapy developers to more easily move from clinical development to commercial manufacturing. The Gibco CTS Xenon Electroporation System leverages [...]
March 16, 2022
Illumina Accelerator portfolio grows to 68 startups 93% of graduate companies successfully secured additional capital SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) has invested in seven new genomics companies to join the fourth global funding cycle of Illumina Accelerator San Francisco Bay Area and Cambridge, UK. The global company creation engine is focused on partnering with entrepreneurs to [...]
Bruker Appoints Philip Ma to its Board of Directors
March 16, 2022
BILLERICA, Mass. -- Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has appointed Philip Ma, Ph.D. to serve on its board, effective as of April 1, 2022. Dr. Ma is Chief Executive Officer, founder, and a director of PrognomiQ, a privately held healthcare company that is developing next-generation, transformative multiomics products to enable [...]

